Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 19NIH 14INDUSTRY 4NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 6Lymphoid 5Other hematologic neoplasm 4Plasma cell 3Genitourinary 3Thoracic 1Sarcoma 1Head & Neck 1Gastrointestinal 1

Conditions

Kidney Neoplasms 2Carcinoma, Renal Cell 2Prostatic Neoplasms 1

Interventions

Radiotherapy 34Gemcitabine 24Docetaxel 24bicalutamide 23Goserelin 21Paclitaxel 19Cisplatin 19Doxorubicin 18Carboplatin 18Flutamide 17Leuprolide 16Radiotherapy, Conformal 13Etoposide 13Filgrastim 12Prednisone 11Gene Expression Profiling 11Gonadotropin-Releasing Hormone 10Radiotherapy, Intensity-Modulated 9Vincristine 8Vinblastine 8Triptorelin Pamoate 8Magnetic Resonance Spectroscopy 8Cyclophosphamide 8Buserelin 8Androgen Antagonists 8Surgical Procedures, Operative 7Radiation 7Polymerase Chain Reaction 7Methotrexate 7Estramustine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Interferon-alpha × Genitourinary × Clear all
NCT00005847 2023-06-22

Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Eastern Cooperative Oncology Group

Phase 2 Completed
Genitourinary

Prostatic Neoplasms

NCT00053807 2012-09-24

Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
96 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00002737 2012-07-11

Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
320 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡